pandem
underlin
impact
emerg
pathogen
major
threat
human
health
develop
quantit
approach
advanc
comprehens
current
outbreak
urgent
need
tackl
sever
diseas
work
sever
mathemat
model
propos
repres
dynam
infect
patient
consid
differ
start
time
infect
paramet
set
repres
infect
comput
compar
viral
infect
also
caus
pandem
base
target
cell
model
infect
time
suscept
cell
mean
day
approxim
much
slower
report
ebola
time
slower
influenza
time
slower
withinhost
reproduct
number
consist
valu
influenza
infect
best
model
fit
data
includ
immun
respons
suggest
slow
cell
respons
peak
day
post
onset
symptom
model
eclips
phase
time
latent
phase
becom
product
infect
cell
support
interestingli
target
cell
model
model
immun
respons
predict
viru
may
replic
slowli
first
day
infect
could
detect
level
first
day
post
infect
quantit
comprehens
dynam
estim
standard
paramet
viral
infect
key
contribut
pioneer
work
none
far
withinhost
level
understand
replic
cycl
interact
immun
system
among
sever
approach
target
cell
model
serv
repres
sever
diseas
hiv
hepat
viru
ebola
influenza
among
mani
other
detail
refer
viral
model
found
recent
data
infect
patient
enlighten
withinhost
viral
dynam
zou
et
al
present
viral
load
nasal
throat
swab
symptomat
patient
interestingli
replic
cycl
may
last
longer
flu
day
incub
period
contribut
mathemat
studi
dynam
withinhost
level
base
data
present
wolfel
et
al
use
ordinari
differenti
equat
ode
differ
mathemat
model
present
adjust
viral
kinet
report
woelfel
et
al
infect
patient
viral
load
cost
function
minim
adjust
model
paramet
base
differenti
evolut
de
algorithm
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
viral
dynam
divid
two
part
exponenti
growth
v
g
decay
v
model
equat
respect
viral
growth
assum
start
onset
symptom
initi
viral
concentr
v
g
paramet
growth
rate
viru
paramet
quantifi
decay
rate
viru
v
initi
valu
viru
decay
phase
note
growth
phase
viru
measur
two
patient
b
exponenti
growth
decay
model
continu
line
simul
base
viral
exponenti
growth
v
g
viral
decay
v
blue
circl
repres
data
viral
growth
rate
comput
patient
till
day
b
till
day
rest
patient
miss
measur
patient
viral
decay
rate
comput
simul
shown
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
tabl
estim
model
use
experiment
data
exponenti
growth
phase
measur
patient
b
rest
patient
logarithm
decay
phase
reason
patient
b
one
report
estim
viral
growth
host
cell
one
follow
state
suscept
u
infect
viral
particl
v
infect
suscept
cell
rate
copiesml
day
cell
product
infect
releas
viru
rate
p
copiesml
day
cell
viru
particl
clear
rate
c
day
infect
cell
clear
rate
day
consequ
cytopath
viral
effect
immun
respons
coronavirus
infect
mainli
differenti
respiratori
epitheli
cell
previou
mathemat
model
influenza
consid
initi
target
cell
u
initi
valu
infect
cell
taken
zero
v
determin
estim
tabl
note
v
measur
detect
level
copiesm
viral
kinet
measur
onset
symptom
howev
unknown
initi
infect
took
place
patient
infect
merscov
show
viru
peak
second
week
ill
indic
median
incub
period
day
rang
paramet
fit
purpos
explor
three
differ
scenario
initi
infect
day
day
onset
symptom
patient
b
see
fig
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
blue
circl
repres
data
due
complet
data
set
patient
b
present
panel
b
respect
infect
time
assum
day
post
symptom
onset
infect
defin
abil
pathogen
establish
infect
quantifi
infect
withinhost
reproduct
number
r
comput
r
defin
expect
number
secondari
infect
produc
infect
cell
r
one
infect
individu
infect
less
one
individu
thu
infect
would
clear
popul
otherwis
r
pathogen
abl
invad
target
cell
popul
epidemiolog
concept
appli
target
cell
model
previou
studi
provid
estim
infect
time
inf
repres
time
requir
singl
infecti
cell
infect
one
cell
virus
shorter
infect
time
higher
infect
equat
inf
explicitli
comput
assum
day
infect
day
post
symptom
onset
pso
would
result
high
reproduct
number
r
high
infect
rate
patient
b
present
tabl
altern
assum
initi
day
infect
either
day
pso
rate
infect
suscept
cell
would
slow
associ
high
replic
rate
p
becom
product
infect
cell
written
follow
cell
eclips
phase
e
becom
product
infect
rate
k
holder
et
al
improv
fit
respect
target
cell
model
tabl
even
long
eclips
phase
period
assum
eg
day
impli
mechan
could
neglig
infect
mathemat
model
immun
respons
previou
studi
acknowledg
relev
immun
tcell
respons
clear
influenza
due
identifi
limit
estim
paramet
target
cell
model
use
viral
load
data
minimalist
model
deriv
repres
interact
viral
immun
respons
dynam
model
assum
viru
v
level
induc
prolifer
cell
follow
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
give
better
fit
previou
model
furthermor
aic
valu
patient
b
highlight
dpso
give
best
fit
present
purpos
numer
result
patient
b
portray
summari
fit
procedur
dpso
present
tabl
independ
start
infect
day
immun
respons
cell
peak
dpso
interestingli
longer
period
infect
time
onset
symptom
higher
immun
respons
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
blue
circl
repres
data
due
complet
data
set
patient
b
present
panel
b
respect
infect
time
assum
day
post
symptom
onset
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
data
show
merscov
level
peak
second
week
median
valu
copiesml
sever
patient
group
copiesml
mild
group
sar
viru
peak
copiesml
day
onset
viral
peak
approxim
copiesml
dpso
liu
et
al
found
patient
sever
diseas
report
mean
viral
load
admiss
time
higher
mean
mild
diseas
case
impli
higher
viral
load
relat
clinic
outcom
addit
higher
viral
load
persist
day
onset
use
target
cell
model
nguyen
et
al
comput
ebola
infect
averag
infect
time
hour
holder
et
al
report
infect
time
wildtyp
wt
pandem
influenza
viru
approxim
hour
base
result
target
cell
model
tabl
found
infect
time
cell
mean
day
approxim
would
slower
report
ebola
time
slower
influenza
time
slower
reproduct
number
influenza
mice
rang
consist
valu
report
interestingli
model
target
cell
model
model
immun
respons
fit
patient
data
predict
viru
replic
detect
level
first
dpi
could
explan
infect
patient
would
take
dpi
exhibit
symptom
model
immun
system
b
highlight
cell
respons
slowli
mount
thu
slow
cell
respons
may
promot
limit
inflamm
level
might
reason
observ
pandem
detriment
outcom
french
patient
use
nonsteroid
antiinflammatori
drug
nad
ibuprofen
howev
far
conclus
clinic
evid
advers
effect
nad
infect
patient
humor
respons
urgent
need
evalu
protect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
infect
nonhuman
primat
model
furthermor
benefit
report
therapeut
treatment
provid
hour
merscov
infect
studi
mainli
address
cell
respons
therefor
futur
model
attempt
direct
establish
detail
model
antibodi
product
crossreact
well
silico
test
differ
antivir
technic
limit
studi
need
highlight
data
kinet
onset
symptom
key
aspect
render
bias
paramet
estim
target
cell
regularli
assum
initi
day
infect
fact
could
miss
viral
dynam
onset
symptom
exampl
throat
sampl
rhesu
macaqu
infect
two
peak
report
anim
dpi
technic
aspect
use
viral
load
target
cell
model
estim
paramet
may
lead
identifi
problem
thu
paramet
valu
taken
caution
paramet
quantif
interpret
address
withinhost
mechan
model
multiscal
level
insight
immunolog
pathogenesi
help
improv
outcom
futur
pandem
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
mathemat
model
base
ordinari
differenti
equat
ode
solv
use
matlab
librari
consid
solv
nonstiff
differenti
equat
clinic
data
individu
due
close
contact
index
case
initi
diagnost
test
admiss
patient
hospit
munich
viral
load
kinet
report
copiesml
per
whole
swab
individu
case
sampl
taken
day
post
symptom
detail
found
n
number
measur
minim
rm
perform
use
differenti
evolut
de
algorithm
note
sever
optim
solver
consid
includ
determinist
f
mincon
matlab
routin
stochast
eg
genet
anneal
algorithm
method
simul
result
reveal
de
global
optim
algorithm
robust
initi
guess
paramet
mention
method
model
select
aic
akaik
inform
criterion
aic
use
compar
goodnessoffit
model
evalu
differ
hypothes
lower
aic
valu
mean
given
model
describ
data
better
model
higher
aic
valu
small
differ
aic
score
eg
signific
small
number
data
point
correct
aicc
write
follow
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
n
number
data
point
number
unknown
paramet
rss
residu
sum
squar
obtain
fit
routin
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
